Comments

Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy"

Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo
Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo
Haematologica Early view Oct 15, 2026 https://doi.org/10.3324/haematol.2026.302093